Erratum to "Research trends in cholangiocarcinoma treatments during the last 3 decades" [Heliyon 9(7) (July 2023) e17100].

Lin, Kainan; Cao, Jiasheng; Chen, Haibo; Topatana, Win; Cai, Jingwei; Zhang, Bin; Hu, Jiahao; Jin, Renan

Lin, Kainan; Cao, Jiasheng; Chen, Haibo; Topatana, Win; Cai, Jingwei; Zhang, Bin; Hu, Jiahao; Jin, Renan.

Afiliación

Lin K; Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310058, Zhejiang Province, China.
Cao J; Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou, 310016, Zhejiang Province, China.
Chen H; Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310058, Zhejiang Province, China.
Topatana W; Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou, 310016, Zhejiang Province, China.
Cai J; Department of Gastrointestinal Surgery, The First People's Hospital of Wenling, Taizhou, 317500, Zhejiang Province, China.
Zhang B; Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310058, Zhejiang Province, China.
Hu J; Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou, 310016, Zhejiang Province, China.
Jin R; Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310058, Zhejiang Province, China.

Heliyon ; 9(9): e19443, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37809857

ABSTRACT

ABSTRACT

[This corrects the article DOI 10.1016/j.heliyon.2023.e17100.].

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Heliyon Año: 2023 Tipo del documento: Article País de afiliación: China